• |
  • |
  • |
  • |
Donate

Project

A Phase 2b, Dose-Ranging Study of the Effect of GS-5745 on FEV1 in Adult Subjects with CF

Center:
Fiscal Year:
2017
Contact Information:
Project Description:
Gilead Sciences, Inc.
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Adults with Disabilities
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A